ADTX
Aditxt, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.00
−16.67%Margins
Gross margin
19.9%
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
156.1%
Return on equity
-373.6%
Return on assets
63.1%
Return on invested capital
0.00x
Asset turnover
-$18.6M
Cash from operations
$0.30
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026